REGEND-008

N/A

Report date: 2024/04/24 10:40:17

Base Information

Drug NameREGEND-008
Drug Alias Name低免疫原性、基因修饰的异体肺前体细胞REGEND008REGEND-008
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangxi Xianhe Medical Technology Co LtdRegend Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRegend Therapeutics Co LtdJiangxi Xianhe Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A